Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API’s, Intermediates and Nutraceutical ingredients
Financial Results:
Divi’s Laboratories Ltd reported Revenues for Q3FY24 of ₹1,855.00 Crores up from ₹1,708.00 Crore year on year, a rise of 8.61%.
Total Expenses for Q3FY24 of ₹1,461.00 Crores up from ₹1,386.00 Crores year on year, a rise of 5.41%.
Consolidated Net Profit of ₹358.00 Crores up 16.99% from ₹306.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹13.49, up 17.00% from ₹11.53 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.